Related Experiment Video
Updated: Aug 16, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
[Lipoprotein (a)]
Insights
Lipoprotein (a) is a key risk factor for cardiovascular disease due to its structure and similarity to plasminogen. Further research is needed to understand its role and develop drugs to lower its levels.
Area of Science:
- Biochemistry
- Cardiovascular Medicine
- Molecular Biology
Context:
- Lipoprotein (a) [Lp (a)] is an LDL particle linked to apolipoprotein (a) [apo (a)].
- Lp (a) is an independent risk factor for atherosclerotic cardiovascular disease.
- Apo (a) shares significant homology with plasminogen, prompting interest in Lp (a)'s atherogenic and thrombotic mechanisms.
Purpose:
- To review recent advances in understanding the atherogenicity and thrombogenicity mechanisms of Lp (a).
- To highlight the need for further research into the physiological role of Lp (a).
- To emphasize the urgent requirement for therapeutic strategies to reduce serum Lp (a) levels.
Summary:
- Recent advances in the atherogenic and thrombotic mechanisms of Lp (a) are reviewed.
- The physiological role of Lp (a) remains largely unknown and requires further investigation.
- Developing drugs to lower serum Lp (a) concentrations is a critical unmet need.
Impact:
- Provides a review of current knowledge on Lp (a) mechanisms.
- Identifies knowledge gaps regarding Lp (a)'s physiological function.
- Underscores the clinical need for Lp (a)-lowering therapies to mitigate cardiovascular risk.
Abstract:
Lipoprotein (a) [Lp (a)] is a low density lipoprotein (LDL) disulfide-linked to apolipoprotein (a) [apo (a)] and considered to be an independent risk factor for atherosclerotic cardiovascular disease. Apo (a) has a high homology with plasminogen, which has stimulated a lot of interest in the mechanism of atherogenicity and thrombogenicity of this lipoprotein. Recent advances in this mechanism were reviewed. We are still unclear about the physiological role of Lp (a). This research aspect must receive attention in the future. Furthermore, the most pressing need is for drugs that will lower serum Lp (a) concentrations.
Related Concept Videos
What are Lipids?
Receptor-mediated Endocytosis
Lipid Digestion
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

